Paroxysmal supraventricular tachycardia (PSVT) is a rapid heart rate resulting from abnormal electrical activity that originates in the tissues above the ventricles of the heart. This form of tachycardia is characterized by sudden episodes of rapid heart rate, which can reach more than 150-250 beats per minute. PSVT is more common in young adults and women, although it can occur in any age group. Attacks are often accompanied by a feeling of weakness, dizziness, shortness of breath, and sometimes chest pain. The disorders that lead to PSVT can have various etiologies, including changes in the cardiac conduction system or the presence of accessory pathways. The condition sometimes requires immediate medical attention, especially if accompanied by signs of hemodynamic instability.
History of the disease and interesting historical facts
The history of the study of paroxysmal supraventricular tachycardia has its roots in the early studies of the heart and its electrical activity. The first descriptions of cardiac arrhythmias related to PSVT were presented in scientific papers in the 19th century, when physicians began to recognize the importance of electrical activity in cardiology. In 1901, Gustav Friedrich wrote about “pelvic attacks,” a phenomenon that we now consider PSVT. However, it was not until the 20th century, with the development of electrocardiography, that physicians were able to more accurately diagnose and classify different types of arrhythmias, including PSVT. In the 1960s, breakthroughs in the treatment of this arrhythmia with medications and the subsequent introduction of radiofrequency catheter ablation dramatically changed the approach to therapy and improved the quality of life of patients.
Epidemiology
PSVT is a fairly common cardiovascular pathology. According to various epidemiological studies, PSVT occurs in 2.3% - 3% people in the general population. PSVT episodes most often occur in young people aged 20 to 40 years, with women suffering from this condition two to three times more often than men. This form of tachycardia can be familial, indicating possible genetic predispositions to its occurrence. It is important to note that PSVT can be observed both within the framework of existing heart diseases and in people without background pathology, which makes its study especially relevant.
Genetic predisposition to this disease
There is evidence of a genetic predisposition to paroxysmal supraventricular tachycardia, although the specific genes associated with the condition have not yet been fully identified. Current research suggests that mutations that may affect the conduction of electrical impulses in the cardiovascular system are of interest to scientists. In particular, changes in genes responsible for ion channels, such as SCN5A, may lead to arrhythmias, including PSVT. Familial predisposition has also been noted early in the study of the condition, highlighting the need for further study of the genetic mechanisms that contribute to PSVT.
Risk factors for the development of this disease
There are several factors that can increase the risk of developing paroxysmal supraventricular tachycardia. These include:
- Stress and emotional tension.
- Consumption of alcohol and caffeine.
- Physical activity, especially for people with weak cardiovascular systems.
- Certain medications, such as sympathomimetics.
- Electrolyte disturbances, such as hypokalemia or hypomagnesemia.
- The presence of organic heart disease, such as coronary heart disease or cardiopathy.
These factors may contribute to the occurrence of PSVT episodes, which requires consideration in their treatment and prevention.
Diagnosis of this disease
Diagnosis of paroxysmal supraventricular tachycardia includes several important stages and methods:
- Main symptoms: rapid heartbeat, dizziness, shortness of breath, external manifestations of rhythm disturbances.
- Laboratory tests: blood tests for electrolyte levels, thyroid function.
- Radiological examinations: echocardiography to evaluate the structure of the heart.
- Other types of disease diagnostics: electrocardiogram (ECG), Holter-type monitoring.
- Differential diagnosis: It is important to rule out other forms of tachycardia and heart disease such as ventricular tachycardia and atrial fibrillation.
These methods help to accurately establish a diagnosis and assess the patient's condition.
Treatment
Treatment for paroxysmal supraventricular tachycardia may vary depending on the frequency and severity of episodes. Common treatment approaches include:
- General treatment: lifestyle changes, including avoiding caffeine and alcohol, and reducing stress.
- Pharmacological treatment: Beta blockers, calcium channel blockers, and antiarrhythmic drugs are often used.
- Surgical treatment: Catheter ablation in case of ineffectiveness of drug therapy.
- Other types of treatment: stress management training and relapse prevention therapy.
These treatment options can be tailored to each patient's needs.
List of medications used to treat this disease
The most commonly used drugs to control paroxysmal supraventricular tachycardia include:
- Adenosine.
- Metoprolol.
- Diltiazem.
- Flecainide.
- Propafenone.
- Sotalol.
- Esmolol.
These drugs help control your heart rate and minimize symptoms.
Disease monitoring
Monitoring of patients with paroxysmal supraventricular tachycardia includes regular examinations and control stages, as well as assessment of therapeutic effectiveness. The prognosis is favorable in most cases, especially with adequate medical care. However, without treatment, complications such as heart failure or the risk of transient ischemia may develop.
Age-related features of the disease
Paroxysmal supraventricular tachycardia may present differently in different age groups. Young patients are more likely to have benign forms that may not require treatment. In older people, PSVT may be associated with other cardiovascular diseases and have more serious consequences. PSVT may also occur in children, but is often associated with congenital heart abnormalities.
Questions and Answers
- What is paroxysmal supraventricular tachycardia?
Paroxysmal supraventricular tachycardia is a rapid heartbeat that occurs due to abnormal electrical activity in the chambers of the heart called the supraventricles. - What symptoms are most commonly associated with PSVT?
The main symptoms of PSVT include rapid heartbeat, dizziness, shortness of breath, and sometimes chest pain. - How is PSVT diagnosed?
Diagnosis is based on an electrocardiogram, clinical symptoms and sometimes requires 24-hour heart rhythm monitoring. - What treatments are available for PSVT?
Treatment includes lifestyle changes, antiarrhythmic drugs, and, in some cases, surgical ablation. - What is the prognosis for patients with PSVT?
The prognosis is generally favorable, especially with timely and adequate treatment.
The importance of a comprehensive approach to the diagnosis and treatment of paroxysmal supraventricular tachycardia should not be underestimated, as this disease can significantly affect the patient's quality of life if not properly controlled.
